A retrospective study to evaluate the effect of Rituximab on growth (in terms of height) and weight in children having steroid-dependent nephrotic syndrome.
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 29 Nov 2015 New trial record